antidepressant - Encircle News!

antidepressant, biology of depression, bipolar disorder, dopamine, entertainment culture, health medical pharma, major depressive disorder, mania, mingzheng wu, mood, mood disorders, mood swing, neuroplasticity, neurotransmitter, reward system, Tech Industry, Tech News, yevgenia kozorovitskiy

Scientists Might Know Why You Feel Loopy After an All-Nighter

November 2, 2023

Ed Cara

Northwestern University scientists may have figured out why pulling an all-nighter can leave us feeling loopy and downright giddy for days after. In a new study out this week, the researchers found that acute sleep deprivation in mice can trigger a rap…
Read more: Scientists Might Know Why You Feel Loopy After an All-Nighter
antidepressant, biology of depression, bipolar disorder, dopamine, entertainment culture, health medical pharma, major depressive disorder, mania, mingzheng wu, mood, mood disorders, mood swing, neuroplasticity, neurotransmitter, reward system, Tech Industry, Tech News, yevgenia kozorovitskiy

Scientists Might Know Why You Feel Loopy After an All-Nighter

November 2, 2023

Ed Cara

Northwestern University scientists may have figured out why pulling an all-nighter can leave us feeling loopy and downright giddy for days after. In a new study out this week, the researchers found that acute sleep deprivation in mice can trigger a rap…
Read more: Scientists Might Know Why You Feel Loopy After an All-Nighter
antidepressant, biology of depression, bipolar disorder, dopamine, entertainment culture, health medical pharma, major depressive disorder, mania, mingzheng wu, mood, mood disorders, mood swing, neuroplasticity, neurotransmitter, reward system, Tech Industry, Tech News, yevgenia kozorovitskiy

Scientists Might Know Why You Feel Loopy After an All-Nighter

November 2, 2023

Ed Cara

Northwestern University scientists may have figured out why pulling an all-nighter can leave us feeling loopy and downright giddy for days after. In a new study out this week, the researchers found that acute sleep deprivation in mice can trigger a rap…
Read more: Scientists Might Know Why You Feel Loopy After an All-Nighter
antidepressant, brenda penninx, health medical pharma, major depressive disorder, management of depression, mental health, moclobemide, selective serotonin reuptake inhibitor, Tech Industry, Tech News, treatment resistant depression

Exercise or Pills for Depression? Study Finds Pros and Cons to Both

October 6, 2023

Ed Cara

New research could complicate the narrative over using exercise to help with depression and other mental health issues. A study compared depressed and/or anxious people who joined a running program to those who took a course of antidepressants, and fou…
Read more: Exercise or Pills for Depression? Study Finds Pros and Cons to Both
antidepressant, entheogens, health medical pharma, legal status of psilocybin mushrooms, major depressive disorder, management of depression, placebo, psilocybin, psilocybin mushroom, psilocybin therapy, Tech Industry, Tech News, treatment resistant depression

Phase II Study Finds That Psilocybin Plus Therapy Can Help Treat Depression Symptoms

September 1, 2023

Ed Cara

New research out this week is the latest to show that psilocybin—the active ingredient in magic mushrooms—can be a viable treatment for depression. The randomized Phase II trial found that a single dose of psilocybin combined with therapy significantly…
Read more: Phase II Study Finds That Psilocybin Plus Therapy Can Help Treat Depression Symptoms
antidepressant, entheogens, health medical pharma, legal status of psilocybin mushrooms, major depressive disorder, management of depression, placebo, psilocybin, psilocybin mushroom, psilocybin therapy, Tech Industry, Tech News, treatment resistant depression

Phase II Study Finds That Psilocybin Plus Therapy Can Help Treat Depression Symptoms

September 1, 2023

Ed Cara

New research out this week is the latest to show that psilocybin—the active ingredient in magic mushrooms—can be a viable treatment for depression. The randomized Phase II trial found that a single dose of psilocybin combined with therapy significantly…
Read more: Phase II Study Finds That Psilocybin Plus Therapy Can Help Treat Depression Symptoms

December 2024
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

TWiT 1011: The Year in Review – A Look at the Top Stories of 2024 – This Week in Tech (Audio)

What's behind the tech industry's mass layoffs in 2024? : NPR Rabbit R1 AI Assistant: Price, Specs, Release Date | WIRED Stealing everything you've ever typed or viewed on your own Windows PC is now possible with two lines of code — inside the Copilot+ Recall disaster. Microsoft delays Recall after security concerns, and asks Windows Insiders for help The Qualcomm Snapdragon X Architecture Deep Dive: Getting To Know Oryon and Adreno X1 Elon Musk: First Human Receives Neuralink Brain Chip Apple hit with €1.8bn fine for breaking EU law over music streaming Bluesky emerges The hidden high cost of return-to-office mandates Apple's Car Was Doomed by Its Lofty Ambitions to Outdo Tesla SpaceX pulls off unprecedented feat, grabs descending rocket with mechanical arms U.S. versus Apple: A first reaction Google Says It Won't Force Gemini on Partners in Antitrust Remedy Proposal U.S. Accuses Chinese Hackers of Targeting Critical Infrastructure in America U.S. Agency Warns Employees About Phone Use Amid Ongoing China Hack AT&T says criminals stole phone records of 'nearly all' customers in new data breach National Public Data confirms breach exposing Social Security numbers Schools Want to Ban Phones. Parents Say No. New York passes legislation that would ban 'addictive' social media algorithms for kids GPT-4o (omni) + new "Her"-style AI assistant (it's nuts) Google emissions jump nearly 50% over five years as AI use surges Trump proposes strategic national crypto stockpile at Bitcoin Conference Ten additional US states join DOJ antitrust lawsuit looking to break up Live Nation and TicketmasterThe Internet Archive just lost its appeal over ebook lending Hezbollah Pagers Explode in Apparent Attack Across Lebanon OpenAI raises $6.6 billion in largest VC round ever Painting by A.I.-Powered Robot Sells for $1.1 Million Netflix's Live Mike Tyson Vs. Jake Paul Fight Battling Sound & Streaming Glitches In Lead-Up To Main Event Infowars Sale to The Onion Rejected by Federal Bankruptcy Judge Supreme Court agrees to hear challenge to TikTok ban So You Want to Solve the NJ Drone Mystery? Our Expert Has Some Ideas Beeper's push for iMessage on Android is really over The Quiet Death of Ello's Big Dreams Japan finally ends mandatory form submission on floppy disks We'll Miss You: Pioneering instant messaging program ICQ is finally shutting down after nearly 30 years Spotify is going to break every Car Thing gadget it ever sold Game Informer to Shut Down After 33 Years In Memoriam Host: Leo Laporte Guests: Fr. Robert Ballecer, SJ, Richard Campbell, and Mikah Sargent Download or subscribe to This Week in Tech at https://twit.tv/shows/this-week-in-tech Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit Sponsor: bitwarden.com/twit

Encircle News!

Category: antidepressant

Scientists Might Know Why You Feel Loopy After an All-Nighter

Scientists Might Know Why You Feel Loopy After an All-Nighter

Scientists Might Know Why You Feel Loopy After an All-Nighter

Exercise or Pills for Depression? Study Finds Pros and Cons to Both

Phase II Study Finds That Psilocybin Plus Therapy Can Help Treat Depression Symptoms

Phase II Study Finds That Psilocybin Plus Therapy Can Help Treat Depression Symptoms

Follow Us

Featured Posts

About Us

Podcasts

TWiT 1011: The Year in Review – A Look at the Top Stories of 2024 – This Week in Tech (Audio)